Zinc alpha2 glycoprotein protects against obesity-induced hepatic steatosis
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Zinc alpha2 glycoprotein protects against obesity-induced hepatic steatosis
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF OBESITY
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2018-07-13
DOI
10.1038/s41366-018-0151-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Zinc alpha2 glycoprotein promotes browning in adipocytes
- (2018) Xin-Hua Xiao et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Nonalcoholic steatohepatitis
- (2018) Natalie H. Bzowej Current Opinion in Organ Transplantation
- The tumor secretory factor ZAG promotes white adipose tissue browning and energy wasting
- (2018) Sawsan Elattar et al. FASEB JOURNAL
- Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
- (2018) Zobair M. Younossi et al. HEPATOLOGY
- Zinc-α2-Glycoprotein Is Associated with Obesity in Chinese People and HFD-Induced Obese Mice
- (2018) Meijuan Liu et al. Frontiers in Physiology
- USP18 protects against hepatic steatosis and insulin resistance through its deubiquitinating activity
- (2017) Shimin An et al. HEPATOLOGY
- Effects of Zinc Alpha2 Glycoprotein on Lipid Metabolism of Liver in High-Fat Diet-Induced Obese Mice
- (2017) Guoqiang Fan et al. HORMONE AND METABOLIC RESEARCH
- Adipokines and Non-Alcoholic Fatty Liver Disease: Multiple Interactions
- (2017) et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Hepatic lipid accumulation: cause and consequence of dysregulated glucoregulatory hormones
- (2017) Caroline E Geisler et al. JOURNAL OF ENDOCRINOLOGY
- Silibinin Capsules improves high fat diet-induced nonalcoholic fatty liver disease in hamsters through modifying hepatic de novo lipogenesis and fatty acid oxidation
- (2017) Chun-Xue Cui et al. JOURNAL OF ETHNOPHARMACOLOGY
- Current and future pharmacological therapies for NAFLD/NASH
- (2017) Yoshio Sumida et al. JOURNAL OF GASTROENTEROLOGY
- Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver
- (2017) P. Dongiovanni et al. JOURNAL OF INTERNAL MEDICINE
- A vicious circle between insulin resistance and inflammation in nonalcoholic fatty liver disease
- (2017) Zhonge Chen et al. Lipids in Health and Disease
- Zinc alpha2 glycoprotein alleviates palmitic acid-induced intracellular lipid accumulation in hepatocytes
- (2017) Xinhua Xiao et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Neuronal zinc-α2-glycoprotein is decreased in temporal lobe epilepsy in patients and rats
- (2017) Ying Liu et al. NEUROSCIENCE
- Circulating zinc-α2-glycoprotein levels are low in newly diagnosed patients with metabolic syndrome and correlate with adiponectin
- (2017) Lu Lei et al. Nutrition & Metabolism
- Targeting nuclear receptors for the treatment of fatty liver disease
- (2017) Naoki Tanaka et al. PHARMACOLOGY & THERAPEUTICS
- Insights into the Hexose Liver Metabolism—Glucose versus Fructose
- (2017) et al. Nutrients
- Effects of Natural Products on Fructose-Induced Nonalcoholic Fatty Liver Disease (NAFLD)
- (2017) Qian Chen et al. Nutrients
- PINK1 alleviates palmitate induced insulin resistance in HepG2 cells by suppressing ROS mediated MAPK pathways
- (2016) Xiaomin Cang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The natural logarithm of zinc-α2-glycoprotein/HOMA-IR is a better predictor of insulin sensitivity than the product of triglycerides and glucose and the other lipid ratios
- (2016) Chunmei Qu et al. CYTOKINE
- Liver PPARα is crucial for whole-body fatty acid homeostasis and is protective against NAFLD
- (2016) Alexandra Montagner et al. GUT
- Tumor necrosis factor receptor-associated factor 5 (Traf5) acts as an essential negative regulator of hepatic steatosis
- (2016) Ling Gao et al. JOURNAL OF HEPATOLOGY
- Targeting hepatic TRAF1-ASK1 signaling to improve inflammation, insulin resistance, and hepatic steatosis
- (2016) Mei Xiang et al. JOURNAL OF HEPATOLOGY
- DKK3 expression in hepatocytes defines susceptibility to liver steatosis and obesity
- (2016) Lanfeng Xie et al. JOURNAL OF HEPATOLOGY
- Adipokines in nonalcoholic fatty liver disease
- (2016) Stergios A. Polyzos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Adiponectin signaling and function in insulin target tissues
- (2016) Hong Ruan et al. Journal of Molecular Cell Biology
- Inactivation of NF-κB p65 (RelA) in Liver Improves Insulin Sensitivity and Inhibits cAMP/PKA Pathway
- (2015) Bilun Ke et al. DIABETES
- Effects of sitagliptin on circulating zinc-α2-glycoprotein levels in newly diagnosed type 2 diabetes patients: a randomized trial
- (2015) Mingyuan Tian et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Carrageenan Inhibits Insulin Signaling through GRB10-mediated Decrease in Tyr(P)-IRS1 and through Inflammation-induced Increase in Ser(P)307-IRS1
- (2015) Sumit Bhattacharyya et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Lipopolysaccharide challenge significantly influences lipid metabolism and proteome of white adipose tissue in growing pigs
- (2015) Jun Guo et al. Lipids in Health and Disease
- Molecular mechanisms of fatty liver in obesity
- (2015) Lixia Gan et al. Frontiers of Medicine
- Circulating anti-inflammatory adipokines High Molecular Weight Adiponectin and Zinc-α2-glycoprotein (ZAG) are inhibited in early sepsis, but increase with clinical recovery: a pilot study
- (2015) Ingeborg D Welters et al. BMC Anesthesiology
- Mindin/Spondin 2 inhibits hepatic steatosis, insulin resistance, and obesity via interaction with peroxisome proliferator-activated receptor α in mice
- (2014) Li-Hua Zhu et al. JOURNAL OF HEPATOLOGY
- Subcutaneous adipose tissue zinc-α2-glycoprotein is associated with adipose tissue and whole-body insulin sensitivity
- (2014) Miroslav Balaz et al. Obesity
- Adiponectin Mediates the Metabolic Effects of FGF21 on Glucose Homeostasis and Insulin Sensitivity in Mice
- (2013) Zhuofeng Lin et al. Cell Metabolism
- Mouse strain-dependent variation in obesity and glucose homeostasis in response to high-fat feeding
- (2013) M. K. Montgomery et al. DIABETOLOGIA
- Insulin signaling, resistance, and metabolic syndrome: insights from mouse models into disease mechanisms
- (2013) Shaodong Guo JOURNAL OF ENDOCRINOLOGY
- Hepatic steatosis exacerbated by endoplasmic reticulum stress-mediated downregulation of FXR in aging mice
- (2013) Xuelian Xiong et al. JOURNAL OF HEPATOLOGY
- Up- and down-regulation of adiponectin expression and multimerization: Mechanisms and therapeutic implication
- (2012) Meilian Liu et al. BIOCHIMIE
- Insulin-sensitive obesity in humans – a ‘favorable fat’ phenotype?
- (2012) D. Samocha-Bonet et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Role of β-adrenergic receptors in the anti-obesity and anti-diabetic effects of zinc-α2-glycoprotien (ZAG)
- (2011) Steven Thomas Russell et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Is zinc-α2-glycoprotein a cardiovascular protective factor for patients undergoing hemodialysis?
- (2011) Viviane O. Leal et al. CLINICA CHIMICA ACTA
- The adipokine zinc-α2-glycoprotein activates AMP kinase in human primary skeletal muscle cells
- (2011) Kristin Eckardt et al. ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY
- Macrophage-secreted factors inhibit ZAG expression and secretion by human adipocytes
- (2010) D. Gao et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started